2,3,4,5-tetrahydroxypentanal has been researched along with Colonic Neoplasms in 3 studies
Colonic Neoplasms: Tumors or cancer of the COLON.
Excerpt | Relevance | Reference |
---|---|---|
"Herein, colon cancer targeting calcium phosphate nanoparticles were developed to carry PSVII to treat drug-resistant colon cancer." | 1.62 | MCP mediated active targeting calcium phosphate hybrid nanoparticles for the treatment of orthotopic drug-resistant colon cancer. ( Bai, S; Cheng, Y; Ji, Q; Jiang, C; Liu, D; Liu, M; Mei, Q; Sun, Y; Ye, W; Zhang, B; Zhou, S, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Bai, S | 1 |
Sun, Y | 1 |
Cheng, Y | 1 |
Ye, W | 1 |
Jiang, C | 1 |
Liu, M | 1 |
Ji, Q | 1 |
Zhang, B | 1 |
Mei, Q | 1 |
Liu, D | 1 |
Zhou, S | 1 |
Sabra, R | 1 |
Billa, N | 1 |
Roberts, CJ | 1 |
Cao, J | 1 |
Yang, J | 1 |
Wang, Z | 1 |
Lu, M | 1 |
Yue, K | 1 |
3 other studies available for 2,3,4,5-tetrahydroxypentanal and Colonic Neoplasms
Article | Year |
---|---|
MCP mediated active targeting calcium phosphate hybrid nanoparticles for the treatment of orthotopic drug-resistant colon cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium Phosphates; Cell Proliferation; Colonic Neoplasms | 2021 |
Cetuximab-conjugated chitosan-pectinate (modified) composite nanoparticles for targeting colon cancer.
Topics: Antineoplastic Agents; Caco-2 Cells; Cell Cycle Checkpoints; Cell Line, Tumor; Cetuximab; Chitosan; | 2019 |
Modified citrus pectins by UV/H
Topics: Acids; Alkalies; Anti-Inflammatory Agents; Antineoplastic Agents; Caco-2 Cells; Colonic Neoplasms; H | 2020 |